Kairos Therapeutics - Web3 Crypto Company Profile, Funding, Valuation, Investors - Cointime

Bitcoin $84,352.98 +0.72%
Ethereum $1,593.35 +1.15%
BNB $585.38 +1.17%
Optimism $0.64 +1.85%
Arbitrum $0.28 +0.94%
Solana $132.96 +6.18%
Polygon $0.22 +2.77%
Cosmos $4.11 +2.92%
Avalanche $19.22 +1.82%

Bitcoin $84,352.98 +0.72%
Ethereum $1,593.35 +1.15%
BNB $585.38 +1.17%
Optimism $0.64 +1.85%
Arbitrum $0.28 +0.94%
Solana $132.96 +6.18%
Polygon $0.22 +2.77%
Cosmos $4.11 +2.92%
Avalanche $19.22 +1.82%

Kairos Therapeutics

company

Summary

About

Kairos Therapeutics is a biopharmaceutical company with a proprietary next-generation antibody-drug conjugate platform.

51 - 100

Details

Industries: Biotechnology,Life Science,Medical
Founded date: Jan 1, 2013
Number Of Employee: 51 - 100
Operating Status: Close